Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: fatigue

ACR Honors Distinguished Fellows at ACR Convergence 2022

Patrice Fusillo  |  October 21, 2022

Editor’s note: This has been extended from the print version to include additional background information on each recipient. Each year, the ACR honors up to 10 clinical and research fellows who have performed meritoriously. Meet this year’s Distinguished Fellows, who are bridging the gap between research and patient care, and who were recognized at ACR…

Filed under:AwardsFrom the CollegeProfessional Topics Tagged with:Dr. Ahmad RamahiDr. Ajay TambralliDr. D. Sofia Villacis NunezDr. Didem SayginDr. Elizabeth ParkDr. Fatima AlduraibiDr. Melanie H. SmithDr. Michael LoncharichDr. Rachel WallworkDr. Rebecca B. BlankFellows

The Rheumatology Research Foundation Invests in Rheumatology Professionals

Katie Robinson  |  October 10, 2022

The mission of the Rheumatology Research Foundation, a division of the ACR, is to advance research and training to improve the health of patients living with rheumatic disease. It supports career advancement, mentorship, professional development and education of professionals working in the disciplines essential to these patients.1 “The Foundation understands that the support of Association…

Filed under:From the CollegeProfessional TopicsResearch RheumWorkforce Tagged with:Association of Rheumatology Professionals (ARP)Rheumatology Research Foundation

A Guiding Light for RA: Insights into Clinical Decision Making, Drug Safety & More

Jason Liebowitz, MD, FACR  |  August 11, 2022

The treatment and management of rheumatoid arthritis (RA) is ever evolving. Here Clifton O. Bingham, MD, discusses the application of RA guidelines, the most recent drug safety information and more.

Filed under:ConditionsMeeting ReportsRheumatoid Arthritis Tagged with:Annual Advances in the Diagnosis & Treatment of the Rheumatic DiseasesDrug SafetyGuidelinesJAK inhibitorsRheumatoid Arthritis (RA)

Updates on PsA: Insights into the Latest Psoriatic Arthritis Treatments & Research

Jason Liebowitz, MD, FACR  |  August 11, 2022

Ana-Maria Orbai, MD, MHS, addressed the latest research into psoriatic arthritis (PsA), including a comprehensive overview of the latest FDA-approved treatments and their implications for clinical practice.

Filed under:ConditionsMeeting ReportsPsoriatic Arthritis Tagged with:Annual Advances in the Diagnosis and Treatment of the Rheumatic DiseasesPsoriatic Arthritisrisankizumabupadacitinib

Difficult-to-Treat Lupus: When & How to Use New Therapies

Samantha C. Shapiro, MD  |  July 21, 2022

Clinicians have numerous treatment options for SLE; in a EULAR 2022 session, some of the newer therapies were reviewed.

Filed under:ConditionsEULAR/OtherMeeting ReportsSystemic Lupus Erythematosus Tagged with:belimumabEULARHCQHydroxychloroquine (HCQ)rituximabSLEsystemic lupus erythematosus (SLE)

Ethics Forum: Billing, Burnout and Protected Non-Clinical Time

Beenish Zulfiqar, MD  |  July 14, 2022

It’s 11 a.m. on a Wednesday. You see a new patient in your fellow’s clinic with impressive physical findings, including a prominent skin rash and deforming arthritis. The patient has been to many doctors and is frustrated that her condition remains undiagnosed and untreated. You thoroughly examine the patient, present her case to your attending…

Filed under:Billing/CodingEthicsPractice SupportProfessional Topics Tagged with:burnoutEthics Forum

Trainee Perspectives on Virtual Applicant Interviews

Didem Saygin, MD, Bethany Marston, MD, Nina Couette, DO, Sara Patrizi, DO, & Adam Kilian, MD  |  July 14, 2022

Since the beginning of the pandemic, the ACR’s Committee on Training and Workforce (COTW) has been interested in better understanding how fellowship recruitment is affected by virtual recruitment from the perspectives of both program directors and trainees. This past year, the COTW conducted a survey study to gain the perspective of program directors.1 The Rheumatology…

Filed under:Career DevelopmentCertificationProfessional TopicsWorkforce Tagged with:FellowsInterviewingrecruitment

A Prescription for Mindfulness

Dana DiRenzo, MD, MHS  |  July 13, 2022

The prescription is a powerful tool for a physician. As rheuma­tologists, we prescribe many things—drugs, physical therapy, durable medical equipment—but what about stress reduction? We are very specific about times of day to take medications and in what manner. Patients ask: With or without food? With other medications? Before or after other prescribed medications? If…

Filed under:AppsEducation & TrainingTechnology Tagged with:meditationmindfulnessself-managementStress

PsA Trial Design Can Improve Patient Safety, Outcomes

Vanessa Caceres  |  June 15, 2022

For best safety and efficacy outcomes, trials in psoriatic arthritis should use active comparators and stricter remission criteria, with outcome measures that are important to patients.

Filed under:ConditionsMeeting ReportsPsoriatic Arthritis Tagged with:ACR-FDA Summitclinical trialsPsoriatic Arthritisstudy design

Lightspring / shutterstock.com

Study Finds Potential Biomarkers for Cardiovascular Risk in Women with Lupus

Elizabeth Hofheinz, MPH, MEd  |  May 12, 2022

When it comes to systemic lupus erythematosus (SLE) and cardio­vascular events (CVEs), the rheumatology community is woefully lacking in information, say researchers from the University of California, Los Angeles (UCLA) David Geffen School of Medicine and Cedars-Sinai Medical Center. Their recent work on biomarkers associated with an increased risk for cardiovascular events in women with…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:Biomarkerscardiovascular eventRisk Factors

  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 62
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences